Americas Gold and Silver Corporation Common Shares no par value vs 22nd Century Group Inc — how do they compare? Americas Gold and Silver Corporation Common Shares no par value trades at $3.91 (market cap $1.36B), while 22nd Century Group Inc trades at $0.65 (market cap $475.95K). The key difference: Americas Gold and Silver Corporation Common Shares no par value is far larger — about 2857.4× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (78,911 versus 3,177,621). Which is the better fit depends on your goals — on Pluang, investors hold Americas Gold and Silver Corporation Common Shares no par value for 0 Days and 22nd Century Group Inc for 33 Days on average.
| USAS | XXII | |
|---|---|---|
Market Cap | $1.36B | $475.95K |
Volume | 3,177,621 | 78,911 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $10.03 | $483.00 |
52-Week Low | $3.59 | $0.65 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $1.29B | -$3.83M |
Signals from Pluang's Aura AI — not financial advice
USAS trades at $4.02, down 4.29% on the day, reflecting ongoing volatility amid mixed operational performance. The company reported a net loss of $87.45M in 2025, though revenue is projected to grow to $182M in 2026 with a narrowing loss. Recent news highlights progress at its Galena and Cosalá mines, including high-grade silver discoveries and sustainability initiatives, signaling potential for future production growth.
The outlook is speculative, with high-risk turnaround potential driven by operational improvements and exposure to silver and critical minerals. Key risks include persistent negative profitability, high valuation multiples like EV/EBITDA of 455.68, and reliance on successful mine development. Analyst consensus is unanimously bullish, but investors must weigh execution risks against long-term growth prospects.
XXII trades at $0.67, down 7.98% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.06 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives in France and Europe.
Despite analyst optimism (75% buy ratings with $1,240 price target), fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces significant execution risk in commercializing reduced-nicotine tobacco products while navigating regulatory timelines.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Americas Gold and Silver Corporation is a Canada-based mining company that explores for and produces silver, along with by-product gold, copper, lead, and zinc. Its operating assets include the Galena Complex in Idaho and the Cosalá Operations in Sinaloa, Mexico.
Read more on USAS →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →